Fujian Aonong Biological Technology Group Incorporation Ltd (603363) - Total Assets

Latest as of September 2025: CN¥9.15 Billion CNY ≈ $1.34 Billion USD

Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) holds total assets worth CN¥9.15 Billion CNY (≈ $1.34 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Fujian Aonong Biological Technology Grou book value and equity for net asset value and shareholders' equity analysis.

Fujian Aonong Biological Technology Group Incorporation Ltd - Total Assets Trend (2013–2024)

This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's total assets have evolved over time, based on quarterly financial data.

Fujian Aonong Biological Technology Group Incorporation Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Fujian Aonong Biological Technology Group Incorporation Ltd's total assets of CN¥9.15 Billion consist of 38.9% current assets and 61.1% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 14.6%
Accounts Receivable CN¥1.13 Billion 11.9%
Inventory CN¥816.94 Million 8.6%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥328.81 Million 3.5%
Goodwill CN¥345.39 Million 3.6%

Asset Composition Trend (2013–2024)

This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 603363 market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Fujian Aonong Biological Technology Group Incorporation Ltd's current assets represent 38.9% of total assets in 2024, a decrease from 70.7% in 2013.
  • Cash Position: Cash and equivalents constituted 14.6% of total assets in 2024, down from 18.3% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2013.
  • Asset Diversification: The largest asset category is accounts receivable at 11.9% of total assets.

Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Total Assets

Key competitors of Fujian Aonong Biological Technology Group Incorporation Ltd based on total assets are shown below.

Company Country Total Assets
SalMar ASA
OL:SALM
Norway Nkr57.95 Billion
Fujian Wanchen Biotechnology Co. Ltd
SHE:300972
China CN¥7.46 Billion
Societe LDC SA
PA:LOUP
France €4.51 Billion
Triputra Agro Persada Tbk PT
JK:TAPG
Indonesia Rp14.70 Trillion
SLC Agrícola S.A
SA:SLCE3
Brazil R$21.34 Billion
FAP Agri Tbk PT
JK:FAPA
Indonesia Rp9.60 Trillion
China Modern Dairy Holdings Ltd
F:07M
Germany €33.39 Billion
Sipef NV
BR:SIP
Belgium €1.21 Billion

Fujian Aonong Biological Technology Group Incorporation Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.02 0.19 0.56
Quick Ratio 0.76 0.12 0.29
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥75.29 Million CN¥-9.91 Billion CN¥-2.72 Billion

Fujian Aonong Biological Technology Group Incorporation Ltd - Advanced Valuation Insights

This section examines the relationship between Fujian Aonong Biological Technology Group Incorporation Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.15
Latest Market Cap to Assets Ratio 0.14
Asset Growth Rate (YoY) -30.2%
Total Assets CN¥9.51 Billion
Market Capitalization $1.28 Billion USD

Valuation Analysis

Below Book Valuation: The market values Fujian Aonong Biological Technology Group Incorporation Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Fujian Aonong Biological Technology Group Incorporation Ltd's assets decreased by 30.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2024)

The table below shows the annual total assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2024.

Year Total Assets Change
2024-12-31 CN¥9.51 Billion
≈ $1.39 Billion
-30.23%
2023-12-31 CN¥13.63 Billion
≈ $1.99 Billion
-26.98%
2022-12-31 CN¥18.66 Billion
≈ $2.73 Billion
+9.12%
2021-12-31 CN¥17.10 Billion
≈ $2.50 Billion
+42.28%
2020-12-31 CN¥12.02 Billion
≈ $1.76 Billion
+144.20%
2019-12-31 CN¥4.92 Billion
≈ $720.19 Million
+48.91%
2018-12-31 CN¥3.31 Billion
≈ $483.63 Million
+30.22%
2017-12-31 CN¥2.54 Billion
≈ $371.40 Million
+48.28%
2016-12-31 CN¥1.71 Billion
≈ $250.48 Million
+26.96%
2015-12-31 CN¥1.35 Billion
≈ $197.29 Million
+45.46%
2014-12-31 CN¥926.86 Million
≈ $135.63 Million
+30.46%
2013-12-31 CN¥710.45 Million
≈ $103.96 Million
--

About Fujian Aonong Biological Technology Group Incorporation Ltd

SHG:603363 China Farm Products
Market Cap
$1.28 Billion
CN¥8.77 Billion CNY
Market Cap Rank
#8081 Global
#2041 in China
Share Price
CN¥3.37
Change (1 day)
-0.59%
52-Week Range
CN¥3.31 - CN¥6.04
All Time High
CN¥26.65
About

Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processi… Read more